Individuals Coming Off Weight-Loss Injections Put On Weight Far More Rapidly Than People Using Diet and Exercise

Fresh analysis indicates that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt traditional diet and exercise regimens.

Findings released in a major medical journal points out that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing these medications should be aware of the risk of quick weight regain when the treatment is stopped," cautioned expert Dr. Susan Jebb.

That rate of recovery implies a return to original weight in about 18 months.

Analyzing Therapies

The research, which looked at dozens of trials involving thousands of participants, contrasted the outcomes of these new drugs with other pills.

Researchers emphasize that individuals who lose weight through diet and exercise usually have a less rapid creep back—approximately 100 grams monthly—once they finish.

Explaining the Quick Rebound

Nutrition scientists believe the mechanism of the injections accounts for the heightened regain.

These medications copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Long-term administration of the hormone levels far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement means hunger is uncontrolled, making binge eating far more likely."

A Chronic Condition?

Health authorities suggest the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Professionals contend that, considering the likelihood of weight regain, the therapy might need to be long-term.

This perspective is echoed by drug manufacturers, who say that the results "emphasize the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.

Patient Accounts

People who have discontinued the jabs describe a powerful return of hunger.

"I experienced a switch activating and you're instantly starving," said an individual.

This difficulty is exacerbated if individuals have not established permanent dietary or behavioural changes during treatment.

Widespread Interest

Survey data show that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire continuing to grow.

• Adoption is more common among females compared to males.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

Ultimately, researchers stress that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic fix and long-term success likely depends on integrated lifestyle support.